Teligent Return on Tangible Equity 2010-2021 | TLGT
Current and historical return on tangible equity values for Teligent (TLGT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Teligent Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2021-06-30 |
$-0.09B |
$-0.06B |
113.23% |
| 2021-03-31 |
$-0.09B |
$-0.05B |
111.04% |
| 2020-12-31 |
$-0.12B |
$-0.13B |
139.43% |
| 2020-09-30 |
$-0.05B |
$-0.08B |
70.68% |
| 2020-06-30 |
$-0.05B |
$-0.07B |
90.21% |
| 2020-03-31 |
$-0.04B |
$-0.07B |
85.15% |
| 2019-12-31 |
$-0.03B |
$-0.05B |
58.14% |
| 2019-09-30 |
$-0.03B |
$-0.05B |
89.47% |
| 2019-06-30 |
$-0.03B |
$-0.04B |
100.00% |
| 2019-03-31 |
$-0.04B |
$-0.04B |
161.62% |
| 2018-12-31 |
$-0.04B |
$-0.03B |
182.28% |
| 2018-09-30 |
$-0.03B |
$-0.02B |
183.61% |
| 2018-06-30 |
$-0.03B |
$-0.02B |
264.00% |
| 2018-03-31 |
$-0.02B |
$-0.02B |
262.50% |
| 2017-12-31 |
$-0.02B |
$-0.01B |
600.00% |
| 2017-09-30 |
$-0.01B |
$-0.01B |
-933.33% |
| 2017-06-30 |
$-0.01B |
$0.00B |
-177.78% |
| 2017-03-31 |
$-0.01B |
$0.01B |
-181.82% |
| 2016-12-31 |
$-0.01B |
$0.00B |
-171.43% |
| 2016-09-30 |
$-0.01B |
$0.01B |
-144.44% |
| 2016-06-30 |
$-0.01B |
$0.01B |
-50.49% |
| 2016-03-31 |
$-0.00B |
$0.01B |
-2.34% |
| 2015-12-31 |
$0.01B |
$0.01B |
13.59% |
| 2015-09-30 |
$0.02B |
$0.07B |
34.08% |
| 2015-06-30 |
$0.02B |
$0.08B |
48.09% |
| 2015-03-31 |
$0.01B |
$0.05B |
44.83% |
| 2014-12-31 |
$0.01B |
$0.03B |
30.77% |
| 2014-09-30 |
$-0.00B |
$0.03B |
-7.14% |
| 2014-06-30 |
$-0.00B |
$0.01B |
-13.79% |
| 2014-03-31 |
$-0.00B |
$0.01B |
-14.81% |
| 2013-12-31 |
$-0.00B |
$0.01B |
-16.00% |
| 2013-09-30 |
$-0.00B |
$0.01B |
-16.67% |
| 2013-06-30 |
$-0.00B |
$0.01B |
-34.78% |
| 2013-03-31 |
$-0.00B |
$0.01B |
-50.00% |
| 2012-12-31 |
$-0.00B |
$0.01B |
-64.00% |
| 2012-09-30 |
$-0.00B |
$0.01B |
-59.26% |
| 2012-06-30 |
$-0.00B |
$0.01B |
-40.00% |
| 2012-03-31 |
$-0.00B |
$0.01B |
-37.50% |
| 2011-12-31 |
$-0.00B |
$0.01B |
-35.29% |
| 2011-09-30 |
$-0.00B |
$0.01B |
-33.33% |
| 2011-06-30 |
$-0.01B |
$0.01B |
-62.50% |
| 2011-03-31 |
$-0.01B |
$0.01B |
-71.43% |
| 2010-12-31 |
$-0.01B |
$0.01B |
-80.00% |
| 2010-09-30 |
$-0.01B |
$0.00B |
-100.00% |
| 2010-06-30 |
$-0.00B |
$0.01B |
-72.73% |
| 2010-03-31 |
$-0.01B |
$0.01B |
-116.67% |
| 2009-12-31 |
$-0.01B |
$0.01B |
-145.45% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
